KRAS4b-PDEδ stablizer C19

CAS No. ——

KRAS4b-PDEδ stablizer C19( —— )

Catalog No. M16988 CAS No. ——

KRAS4b-PDEδ stablizer C19 is a small molecule that binds and stablizes the KRAS4b-PDEδ complex.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    KRAS4b-PDEδ stablizer C19
  • Note
    Research use only, not for human use.
  • Brief Description
    KRAS4b-PDEδ stablizer C19 is a small molecule that binds and stablizes the KRAS4b-PDEδ complex.
  • Description
    KRAS4b-PDEδ stablizer C19 is a small molecule that binds and stablizes the KRAS4b-PDEδ complex, decreases the viability and proliferation of colorectal cancer cells; showed high cytotoxicity in the colorectal cancer cell lines HCT116 and LoVo, with a stronger effect in KRAS-dependent LoVo cells. Importantly, C19 significantly decreased tumor size in a xenograft mouse model and showed lower side effects than 5-FU.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    Ras
  • Recptor
    Ras
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    ——
  • Formula Weight
    385.285
  • Molecular Formula
    C18H22Cl2N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    (2S)-N-(2,5-dichlorophenyl)-2-(((3,4-dimethoxycyclohexa-2,5-dien-1-yl)methyl)amino)propanamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Cruz-Nova P, et al. BMC Cancer. 2018 Nov 1;18(1):1056.
molnova catalog
related products
  • ARS-853

    ARS-853 is a mutant-specific, covalent inhibitor of KRAS(G12C); engages KRASG12C in biochemical assay with a rate constant of 76 M-1s-1.

  • NSC 23766

    A specific small molecule inhibitor of Rac GTPase.

  • Antineoplaston A10(b...

    Antineoplaston A 10 is a Ras inhibitor potentially for the treatment of glioma lymphoma astrocytoma and breast cancer.